Paulina Deming earned a B.S. in Biology and a Doctor of Pharmacy degree from the University of New Mexico. Following her PharmD degree, she completed a pharmacy practice residency and subsequently an infectious diseases pharmacotherapy residency. Dr. Deming's clinical practice and research is focused on hepatitis C virus (HCV) infections. Dr. Deming works with partners in the community, correctional facilities, as well as with Indian Health Services/Tribal/Urban Indian health programs to expand access to HCV care by providing HCV training and faculty expertise. Her current interests include HCV elimination programs, chronic HCV treatment outcomes, and chronic hepatitis B virus infections.

Personal Statement

My work focuses on chronic hepatitis C virus infections and improving access to treatment to this very curable infection. Although HCV treatment was historically focused on specialist care, current therapies are well tolerated, highly effective, and should be provided by non-specialists in order to effectively address the HCV epidemic. Viral HCV disproportionately affects people who are socially marginalized and with limited access to healthcare. Pharmacists can extend the reach of medical care and provide these curative therapies to our communities. Through my teaching at the college and my work through the ECHO institute, my goal is to improve knowledge about HCV and improve HCV treatment access to improve the health of our communities (

Areas of Specialty

Hepatitis C Virus Infections
Hepatitis B Virus Infections
Chronic Liver Disease


PharmD, University of New Mexico, 2004
BS, University of New Mexico, 1997 (Biology)

Achievements & Awards

New Mexico Society of Health Systems Pharmacists Dorothy Dillon Memorial Lecture Award Recipient 2018

University of New Mexico College of Pharmacy Faculty Preceptor of the Year Award 2017

University of New Mexico College of Pharmacy P3 Students’ Faculty Appreciation Award2016

Society of Infectious Disease Pharmacists: Gita Patel Best Practices Recognition Award 2014


  • Polish

Research and Scholarship

Mera J, Joshi K, Thornton K, Box T, Scott J, Sedillo M, Deming P, David C, Essex W, Manch R, Kohli A. Retrospective study demonstrating high rates of sustained virologic response after treatment with direct-acting antivirals among American Indian/Alaskan Natives. Open Forum Infect Dis. 2019;6: ofz128. doi: 10.1093/ofid/ofz128

Martin MT, Deming P. Closing the Gap: The challenges of treating hepatitis C virus genotype 3 infection. Pharmacotherapy. 2017;37:735-747.

Deming P, Martin MT, Chan J, Dilworth TJ, El-Lababidi R, Love BL, Mohammadra R, Nguyen A, Spooner LM, Wortman SB. Therapeutic advances in HCV genotype 1 infection: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2016 Feb; 36:203-17.

Mohammad RA, Bulloch MN, Chan J, Deming P, Love B, Smith L, Dong BJ. Provision of clinical pharmacist services for individuals with chronic hepatitis C viral infection. Joint Opinion Paper of the GI/Liver/Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy. Pharmacotherapy 2014;34:1341-1354.

Arora S, Thornton K, Murata G, Deming P, Kalishman S, Dion D, Parish B, Burke T, Pak W, Dunkelberg J, Kistin M, Brown J, Jenkusky S, Komaromy M, Qualls C. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 2011 Jun 9;364(23):2199-207.